Reuters Photojournalism
Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography. See more | Photo caption
The SpaceX mission
A privately owned unmanned rocket blasts off on a mission to be the first commercial flight to the International Space Station. Slideshow
Canada approves H1N1 vaccine, clears way for use
Canadian Health Minister Leona Aglukkaq (L) visits a lab that tests for the H1N1 flu virus at the British Columbia Centre for Disease Control in Vancouver, British Columbia October 16, 2009.
Credit: Reuters/Andy Clark
OTTAWA |
OTTAWA (Reuters) - The Canadian government has approved the H1N1 vaccine made by GlaxoSmithKline Plc, clearing the way for its general use in the population, federal health spokeswoman Josee Bellemare said on Wednesday.
Canada has ordered 50.4 million doses from the company and at least 2 million have already been sent around the country, but regulatory approval was required before they could be used.
The federal government had initially slated the first week of November for the start of the vaccinations, but provincial governments, which are responsible for health care in Canada, will now be able to start whenever they are ready.
(Reporting by Randall Palmer; editing by Peter Galloway)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters